Calidi Biotherapeutics (CLDI) Liabilities and Shareholders Equity (2021 - 2026)
Calidi Biotherapeutics (CLDI) recorded Liabilities and Shareholders Equity of $7.2 million in Q2 2026, down 23.0% from $9.35 million a year earlier.
Powered by 
Analysis
Calidi Biotherapeutics (CLDI) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends
At the end of FY2025, Calidi Biotherapeutics reported Liabilities and Shareholders Equity of $8.86 million, down 37.5% from FY2024.
- Annual Liabilities and Shareholders Equity has a four-year compound annual growth rate of -55.8% (FY2021 to FY2025).
- Across earlier years, Liabilities and Shareholders Equity came in at $14.18 million in FY2024 (+41.6%), $10.02 million in FY2023 (+285.8%), $2.6 million in FY2022 (-98.9%) and $231.77 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Liabilities and Shareholders Equity since Q3 2024.
- On a year-over-year basis, Liabilities and Shareholders Equity rose in four of the last seven quarters, with growth averaging 25.2%.
- Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 285.8% in Q4 2023, against a decline of 98.9% in Q4 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Calidi Biotherapeutics | 1.50 Mn | -23.88 Mn | - | 7.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.20 Mn |
| Dec 31, 2025 | 8.86 Mn |
| Sep 30, 2025 | 14.03 Mn |
| Jun 30, 2025 | 9.35 Mn |
| Mar 31, 2025 | 15.06 Mn |
| Dec 31, 2024 | 14.18 Mn |
| Sep 30, 2024 | 6.66 Mn |
| Jun 30, 2024 | 6.43 Mn |
| Mar 31, 2024 | 7.41 Mn |
| Dec 31, 2023 | 10.02 Mn |
| Sep 30, 2023 | 18.59 Mn |
| Jun 30, 2023 | 44.01 Mn |
| Mar 31, 2023 | 43.18 Mn |
| Dec 31, 2022 | 2.60 Mn |
| Sep 30, 2022 | 42.16 Mn |
| Jun 30, 2022 | 231.02 Mn |
| Mar 31, 2022 | 231.24 Mn |
| Dec 31, 2021 | 231.77 Mn |
API Access
Calidi Biotherapeutics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CLDI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "CLDI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CLDI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();